Φορτώνει......

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

The triple drug combination consisting of irinotecan, oxaliplatin and 5-fluorouracil (FOLFOXIRI) has demonstrated higher activity and efficacy compared to the doublet FOLFIRI. 5-Fluorouracil could be substituted in FOLFOXIRI regimen by capecitabine, an oral fluoropyrimidine with similar efficacy. Re...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Vasile, E, Masi, G, Fornaro, L, Cupini, S, Loupakis, F, Bursi, S, Petrini, I, Di Donato, S, Brunetti, I M, Ricci, S, Antonuzzo, A, Chiara, S, Amoroso, D, Andreuccetti, M, Falcone, A
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Publishing Group 2009
Θέματα:	Clinical Study
Διαθέσιμο Online:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2695688/ https://ncbi.nlm.nih.gov/pubmed/19436300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605075
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer

Παρόμοια τεκμήρια